Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
about
What in vitro models of infection can and cannot do.Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution modelsBactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelPharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coliKilling of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.In vitro pharmacodynamic models to determine the effect of antibacterial drugs.Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.Optimal control strategies for disinfection of bacterial populations with persister and susceptible dynamics.
P2860
Q34443398-E4023A76-8838-48D5-8520-6CB9D3C0D37FQ35114219-484852D5-1BC9-4ECB-BD45-615AFAD180D1Q35117243-F05A3AF6-C1E6-48E3-8FE3-2CE9981A3FE2Q35117352-95D8D177-C073-4A41-8569-F67FC41C510AQ35124263-717A889F-9373-4C47-959A-EE3A259F1895Q35128808-C57BBA20-0C22-455C-A911-B73EB614DE4DQ35566354-432953EC-F50B-41E9-8F7F-2392FF883B58Q35820123-24187ED8-1B83-4732-98B2-0B04280E18B3Q37660762-55396817-561D-4685-8F04-4E43B969B05AQ39781591-575A61A7-D4A2-412A-AF0F-0C0AB2FBD013Q39874925-CD83FFB8-7640-410C-ADD9-22581B2FEB60Q42281285-BE49A885-B6B3-4D93-B246-F5958B768DAE
P2860
Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
@en
type
label
Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
@en
prefLabel
Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
@en
P2093
P2860
P356
P1476
Artifacts in dilution pharmacokinetic models caused by adherent bacteria.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.5.765
P407
P577
1986-05-01T00:00:00Z